Literature DB >> 30004624

Effects of remifentanil maintenance during recovery on emergence delirium in children with sevoflurane anesthesia.

Eun Kyung Choi1, Shiback Lee1, Won Jae Kim2, Sang-Jin Park1.   

Abstract

BACKGROUND: Emergence delirium is a common complication of sevoflurane anesthesia in children. AIMS: We examined the effects of maintaining remifentanil infusion during the recovery period on the incidence of emergence delirium in preschool-age children undergoing strabismus surgery under sevoflurane anesthesia.
METHODS: Eighty children (aged 3-7 years) were randomly assigned to either the control group (group C; intraoperative remifentanil infusion) or the intervention group (group R; intraoperative remifentanil infusion followed by remifentanil maintenance during the recovery phase). Intraoperative remifentanil infusion (0.2 μg/kg/min) was discontinued upon surgery completion in the group C, and was maintained until the discharge criteria were met at a dose of 0.05 μg/kg/min in the group R. The incidence of emergence delirium was assessed using a five-point agitation scale and the Pediatric Anesthesia Emergence Delirium scale after arrival in the postanesthesia care unit. Postoperative pain was assessed using the Children's Hospital of Eastern Ontario Pain Scale.
RESULTS: The incidence of emergence delirium according to the five-point agitation scale (scores ≥ 4) was lower in the group R (33.3%) compared to the group C (68.3%) (odds ratio 0.206; 95% CI 0.080 to 0.531; P = 0.002). Similar results were obtained using the Pediatric Anesthesia Emergence Delirium scale (scores > 12), with an incidence of 5.1% in the group R and 34.0% in the control group (odds ratio 0.104; 95% CI 0.022 to 0.497; P = 0.001). The Children's Hospital of Eastern Ontario Pain Scale scores and occurrence of postoperative adverse events including laryngospasm, desaturation, nausea, and vomiting were similar between the two groups.
CONCLUSION: Maintaining a low dose of remifentanil (0.05 μg/kg/min) throughout the recovery phase attenuated the incidence of emergence delirium in children undergoing strabismus surgery under sevoflurane anesthesia.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  anesthesia; emergence delirium; sevoflurane

Mesh:

Substances:

Year:  2018        PMID: 30004624     DOI: 10.1111/pan.13446

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  6 in total

1.  The Effects of Different Doses of Alfentanil and Dexmedetomidine on Prevention of Emergence Agitation in Pediatric Tonsillectomy and Adenoidectomy Surgery.

Authors:  Yan-Zhuo Zhang; Xiong-Li Wei; Bin Tang; Yuan-Yuan Qin; Min Ou; Xiao-Hong Jiang; Yu-Feng Tan; Mao-Ying Ye
Journal:  Front Pharmacol       Date:  2022-02-02       Impact factor: 5.810

2.  Effect of Remifentanil on Postoperative Vomiting After Strabismus Surgery in Preschool Children: A Prospective Randomized Controlled Trial.

Authors:  Hyun-Seong Lee; Ki Hwa Lee; Byeongcheol Lee; Daeseok Oh; Sung Hyun Shin; Yei Heum Park
Journal:  Anesth Pain Med       Date:  2022-02-26

3.  Effects of remifentanil on the recovery quality among pediatric candidates for dental procedures under general anesthesia.

Authors:  Nosrat Nourbakhsh; Nasser Kaviani; Reza Salari-Moghaddam; Shirin Marzoughi
Journal:  Dent Res J (Isfahan)       Date:  2022-02-28

4.  Effect of ancillary drugs on sevoflurane related emergence agitation in children undergoing ophthalmic surgery: a Bayesian network meta-analysis.

Authors:  Dan Tan; Haifa Xia; Shujun Sun; Fuquan Wang
Journal:  BMC Anesthesiol       Date:  2019-08-01       Impact factor: 2.217

5.  Comparative Effects of Total Intravenous Anesthesia with Propofol and Remifentanil Versus Inhalational Sevoflurane with Dexmedetomidine on Emergence Delirium in Children Undergoing Strabismus Surgery.

Authors:  Mohamed E Oriby; Ayman Elrashidy
Journal:  Anesth Pain Med       Date:  2020-12-20

6.  [Oral trans-mucosal dexmedetomidine for controlling of emergence agitation in children undergoing tonsillectomy: a randomized controlled trial].

Authors:  Hala S Abdel-Ghaffar; Amani H Abdel-Wahab; Mohammed M Roushdy
Journal:  Braz J Anesthesiol       Date:  2019-10-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.